Description of the condition

Adult Polyglucosan Body Disease (APBD), also known as Polyglucosan Body Disease (PBD), is a rare genetic disorder characterised by the accumulation of abnormal glycogen deposits in various tissues, particularly the nervous system. APBD typically presents in adulthood and is caused by mutations in the GBE1 gene. It leads to neurological symptoms such as muscle weakness, neuropathy, difficulty walking, and urinary problems. Treatment mainly focuses on managing symptoms and providing supportive care to improve the individual’s quality of life.

Newly diagnosed?

A new diagnosis can be overwhelming as it brings unique challenges and adjustments, but it is important to remember that you are not alone.

Get support

Cause

Mutations in the GBE1 gene cause this disease. The GBE1 creates a glycogen branching enzyme which is involved in producing a sugar called glycogen, a source of stored energy. When mutations occur, the enzyme creates abnormal glycogen molecules called Polyglucosan bodies. These accumulate and cause damage, particularly to nerve cells, although the reasons for this are not fully understood.

The disease does not always correlate with enzyme activity, so it is not clear how the mutations have caused the disease. In others with this condition, there is no mutation to the GBE1 gene and the genetic cause of the disease is unknown.

Inheritance

Autosomal recessive: In autosomal recessive conditions, two copies of the genetic mutation are needed to cause the condition. We all have two copies of every gene, one from our mother and one from our father. The parents of someone with an autosomal recessive condition both carry one copy of the gene with a genetic mutation. Therefore, someone with an autosomal recessive condition has two copies of the genetic mutation, one copy from each parent. Each child of parents that both carry the genetic mutation will have a 25% chance of having the condition, a 50% chance of carrying the genetic mutation (like the parent), and a 25% chance of not having the condition.

This image shows the inheritance of genes from parents to their children and the resulting combination of genes the child will have. Red represents the genetic mutation, blue represents the normal copy of the gene. The line from each parent shows which gene they pass on to their child. The colours of the individuals tell the effect of the genes they have, red means they will be at risk of being affected, blue means they will not be at risk of being affected, and yellow means they carry the mutated gene.

Genetic counselling

Genetic counselling is essential for affected families due to the inheritance pattern of the condition. This is available at hospitals and Regional Genetic Centres. Please contact your doctor if you have any questions.

Learn more about genetic testing and counselling here.

Symptoms

The first symptom of APBD is almost always bladder related, leading to near complete loss of bladder control or urinary incontinence. This can happen up to 20 years before other symptoms. Neuropathy is also a common early symptom, including an inability to lift the front of the foot, known as foot drop.

Weakness in the arms and legs can progress to walking difficulties and spasticity. Mild cognitive impairment may occur and some will develop dementia.

More symptom information

Learn more about specific symptoms of this leukodystrophy in these pages.

Treatments

Although there is currently no specific treatment for this leukodystrophy, there is condition management information that may be useful for you in managing your or your loved ones leukodystrophy.

Current research

There may be a current clinical trial, natural history study or patient registry for your condition. Check our current research page and ask your specialist doctor for more information.

Scientific research

We understand that research is a significant priority and source of hope for the leukodystrophy community. There is more research in leukodystrophy now than ever before. Alex TLC actively promotes and supports research in a number of ways.

Every month we update our database of research summaries with the most recent research. This includes summaries of leukodystrophy articles, clinical trials and pharmaceutical press releases. Our summaries allow our community to read about relevant recent research developments in a format that is easily understood.

How we can support you

Learn about the ways in which we can help in the how we support you section. When you or a family member been diagnosed with a leukodystrophy it may be difficult to know where to go for more advice – this information could help.

How we support you

Services and equipment

Our services and equipment section is here to help leukodystrophy patients and their families manage their condition. All information is based on our knowledge of UK services, however, our team are happy to receive support requests from other countries – email us.

Services and equipment

Healthcare professionals

You may be introduced to many different medical professionals which you may find confusing. View our guide to the health and care professionals you may encounter, with short descriptions about what they do.

Health and care professionals

Other resources

Links to useful information

We take great care in only selecting credible, useful links and resources, however we cannot be held responsible for the content of external websites or other sources.

View the full list of leukodystrophies